nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Rosuvastatin—atherosclerosis	0.0976	0.179	CbGbCtD
Vardenafil—CYP3A5—Simvastatin—atherosclerosis	0.0907	0.166	CbGbCtD
Vardenafil—CYP3A5—Pravastatin—atherosclerosis	0.0888	0.162	CbGbCtD
Vardenafil—CYP3A5—Lovastatin—atherosclerosis	0.0888	0.162	CbGbCtD
Vardenafil—CYP3A4—Ezetimibe—atherosclerosis	0.0381	0.0696	CbGbCtD
Vardenafil—CYP3A4—Rosuvastatin—atherosclerosis	0.0381	0.0696	CbGbCtD
Vardenafil—CYP3A4—Simvastatin—atherosclerosis	0.0354	0.0647	CbGbCtD
Vardenafil—CYP3A4—Pravastatin—atherosclerosis	0.0346	0.0633	CbGbCtD
Vardenafil—CYP3A4—Lovastatin—atherosclerosis	0.0346	0.0633	CbGbCtD
Vardenafil—PDE5A—penis—atherosclerosis	0.0123	0.261	CbGeAlD
Vardenafil—PDE5A—artery—atherosclerosis	0.00571	0.121	CbGeAlD
Vardenafil—PDE5A—endothelium—atherosclerosis	0.00482	0.102	CbGeAlD
Vardenafil—PDE5A—blood vessel—atherosclerosis	0.00445	0.0942	CbGeAlD
Vardenafil—PDE11A—liver—atherosclerosis	0.00322	0.0683	CbGeAlD
Vardenafil—PDE6G—liver—atherosclerosis	0.0031	0.0657	CbGeAlD
Vardenafil—PDE10A—adipose tissue—atherosclerosis	0.00299	0.0633	CbGeAlD
Vardenafil—PDE1B—adipose tissue—atherosclerosis	0.00296	0.0627	CbGeAlD
Vardenafil—PDE5A—connective tissue—atherosclerosis	0.00228	0.0483	CbGeAlD
Vardenafil—PDE5A—cardiovascular system—atherosclerosis	0.00198	0.042	CbGeAlD
Vardenafil—PDE5A—adipose tissue—atherosclerosis	0.00175	0.037	CbGeAlD
Vardenafil—Pharyngitis—Rosuvastatin—atherosclerosis	0.00108	0.00413	CcSEcCtD
Vardenafil—Liver function test abnormal—Niacin—atherosclerosis	0.00106	0.00404	CcSEcCtD
Vardenafil—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00105	0.00402	CcSEcCtD
Vardenafil—Orthostatic hypotension—Niacin—atherosclerosis	0.00105	0.004	CcSEcCtD
Vardenafil—Liver function test abnormal—Pravastatin—atherosclerosis	0.00104	0.00398	CcSEcCtD
Vardenafil—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00103	0.00395	CcSEcCtD
Vardenafil—Cramp muscle—Pravastatin—atherosclerosis	0.00102	0.00388	CcSEcCtD
Vardenafil—Infestation NOS—Ezetimibe—atherosclerosis	0.00101	0.00385	CcSEcCtD
Vardenafil—Infestation—Ezetimibe—atherosclerosis	0.00101	0.00385	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000996	0.0038	CcSEcCtD
Vardenafil—Influenza—Niacin—atherosclerosis	0.000991	0.00379	CcSEcCtD
Vardenafil—Dysphagia—Niacin—atherosclerosis	0.000991	0.00379	CcSEcCtD
Vardenafil—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000985	0.00376	CcSEcCtD
Vardenafil—Influenza—Pravastatin—atherosclerosis	0.000976	0.00373	CcSEcCtD
Vardenafil—Angina pectoris—Niacin—atherosclerosis	0.000966	0.00369	CcSEcCtD
Vardenafil—Sinusitis—Lovastatin—atherosclerosis	0.000966	0.00369	CcSEcCtD
Vardenafil—Mental disorder—Rosuvastatin—atherosclerosis	0.000955	0.00365	CcSEcCtD
Vardenafil—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000955	0.00365	CcSEcCtD
Vardenafil—Angina pectoris—Pravastatin—atherosclerosis	0.000951	0.00363	CcSEcCtD
Vardenafil—Sinusitis—Ezetimibe—atherosclerosis	0.000947	0.00362	CcSEcCtD
Vardenafil—Sinusitis—Simvastatin—atherosclerosis	0.000903	0.00345	CcSEcCtD
Vardenafil—Pharyngitis—Ezetimibe—atherosclerosis	0.000899	0.00343	CcSEcCtD
Vardenafil—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000891	0.0034	CcSEcCtD
Vardenafil—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00089	0.0034	CcSEcCtD
Vardenafil—Angioedema—Rosuvastatin—atherosclerosis	0.000867	0.00331	CcSEcCtD
Vardenafil—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000858	0.00328	CcSEcCtD
Vardenafil—Flushing—Lovastatin—atherosclerosis	0.000857	0.00327	CcSEcCtD
Vardenafil—Myocardial infarction—Pravastatin—atherosclerosis	0.000853	0.00326	CcSEcCtD
Vardenafil—Sweating—Niacin—atherosclerosis	0.000847	0.00324	CcSEcCtD
Vardenafil—Flushing—Ezetimibe—atherosclerosis	0.000841	0.00321	CcSEcCtD
Vardenafil—Angiopathy—Ezetimibe—atherosclerosis	0.000822	0.00314	CcSEcCtD
Vardenafil—Immune system disorder—Ezetimibe—atherosclerosis	0.000818	0.00313	CcSEcCtD
Vardenafil—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000817	0.00312	CcSEcCtD
Vardenafil—Sinusitis—Pravastatin—atherosclerosis	0.000816	0.00312	CcSEcCtD
Vardenafil—Arthralgia—Rosuvastatin—atherosclerosis	0.000808	0.00309	CcSEcCtD
Vardenafil—Myalgia—Rosuvastatin—atherosclerosis	0.000808	0.00309	CcSEcCtD
Vardenafil—Flushing—Simvastatin—atherosclerosis	0.000802	0.00306	CcSEcCtD
Vardenafil—Haemoglobin—Niacin—atherosclerosis	0.000797	0.00305	CcSEcCtD
Vardenafil—Rhinitis—Niacin—atherosclerosis	0.000795	0.00304	CcSEcCtD
Vardenafil—Mental disorder—Ezetimibe—atherosclerosis	0.000794	0.00303	CcSEcCtD
Vardenafil—Haemorrhage—Niacin—atherosclerosis	0.000793	0.00303	CcSEcCtD
Vardenafil—Hypoaesthesia—Niacin—atherosclerosis	0.000789	0.00301	CcSEcCtD
Vardenafil—Erythema—Ezetimibe—atherosclerosis	0.000789	0.00301	CcSEcCtD
Vardenafil—Rhinitis—Pravastatin—atherosclerosis	0.000783	0.00299	CcSEcCtD
Vardenafil—Back pain—Lovastatin—atherosclerosis	0.000778	0.00297	CcSEcCtD
Vardenafil—Hypoaesthesia—Pravastatin—atherosclerosis	0.000777	0.00297	CcSEcCtD
Vardenafil—Pharyngitis—Pravastatin—atherosclerosis	0.000775	0.00296	CcSEcCtD
Vardenafil—Muscle spasms—Lovastatin—atherosclerosis	0.000773	0.00295	CcSEcCtD
Vardenafil—Infection—Rosuvastatin—atherosclerosis	0.000769	0.00294	CcSEcCtD
Vardenafil—Visual impairment—Niacin—atherosclerosis	0.000765	0.00292	CcSEcCtD
Vardenafil—Back pain—Ezetimibe—atherosclerosis	0.000763	0.00291	CcSEcCtD
Vardenafil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00076	0.0029	CcSEcCtD
Vardenafil—Muscle spasms—Ezetimibe—atherosclerosis	0.000758	0.0029	CcSEcCtD
Vardenafil—Vision blurred—Lovastatin—atherosclerosis	0.000758	0.00289	CcSEcCtD
Vardenafil—Mental disorder—Simvastatin—atherosclerosis	0.000757	0.00289	CcSEcCtD
Vardenafil—Visual impairment—Pravastatin—atherosclerosis	0.000753	0.00288	CcSEcCtD
Vardenafil—Erythema—Simvastatin—atherosclerosis	0.000752	0.00287	CcSEcCtD
Vardenafil—Ill-defined disorder—Lovastatin—atherosclerosis	0.000746	0.00285	CcSEcCtD
Vardenafil—Eye disorder—Niacin—atherosclerosis	0.000742	0.00283	CcSEcCtD
Vardenafil—Tinnitus—Niacin—atherosclerosis	0.00074	0.00283	CcSEcCtD
Vardenafil—Flushing—Niacin—atherosclerosis	0.000736	0.00281	CcSEcCtD
Vardenafil—Angioedema—Lovastatin—atherosclerosis	0.000735	0.00281	CcSEcCtD
Vardenafil—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000732	0.00279	CcSEcCtD
Vardenafil—Tinnitus—Pravastatin—atherosclerosis	0.000728	0.00278	CcSEcCtD
Vardenafil—CYP3A5—adipose tissue—atherosclerosis	0.000727	0.0154	CbGeAlD
Vardenafil—Malaise—Lovastatin—atherosclerosis	0.000725	0.00277	CcSEcCtD
Vardenafil—Cardiac disorder—Pravastatin—atherosclerosis	0.000725	0.00277	CcSEcCtD
Vardenafil—Flushing—Pravastatin—atherosclerosis	0.000725	0.00277	CcSEcCtD
Vardenafil—Muscle spasms—Simvastatin—atherosclerosis	0.000723	0.00276	CcSEcCtD
Vardenafil—Vertigo—Lovastatin—atherosclerosis	0.000723	0.00276	CcSEcCtD
Vardenafil—Angioedema—Ezetimibe—atherosclerosis	0.000721	0.00275	CcSEcCtD
Vardenafil—Angiopathy—Niacin—atherosclerosis	0.00072	0.00275	CcSEcCtD
Vardenafil—Malaise—Ezetimibe—atherosclerosis	0.000711	0.00272	CcSEcCtD
Vardenafil—Vision blurred—Simvastatin—atherosclerosis	0.000709	0.00271	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000706	0.00269	CcSEcCtD
Vardenafil—Insomnia—Rosuvastatin—atherosclerosis	0.000701	0.00267	CcSEcCtD
Vardenafil—Ill-defined disorder—Simvastatin—atherosclerosis	0.000698	0.00267	CcSEcCtD
Vardenafil—Palpitations—Ezetimibe—atherosclerosis	0.000697	0.00266	CcSEcCtD
Vardenafil—Paraesthesia—Rosuvastatin—atherosclerosis	0.000695	0.00266	CcSEcCtD
Vardenafil—Erythema—Niacin—atherosclerosis	0.000691	0.00264	CcSEcCtD
Vardenafil—Angioedema—Simvastatin—atherosclerosis	0.000687	0.00262	CcSEcCtD
Vardenafil—Myalgia—Lovastatin—atherosclerosis	0.000685	0.00261	CcSEcCtD
Vardenafil—Arthralgia—Lovastatin—atherosclerosis	0.000685	0.00261	CcSEcCtD
Vardenafil—Chest pain—Lovastatin—atherosclerosis	0.000685	0.00261	CcSEcCtD
Vardenafil—Anxiety—Lovastatin—atherosclerosis	0.000682	0.00261	CcSEcCtD
Vardenafil—Dyspepsia—Rosuvastatin—atherosclerosis	0.000682	0.0026	CcSEcCtD
Vardenafil—Malaise—Simvastatin—atherosclerosis	0.000678	0.00259	CcSEcCtD
Vardenafil—Discomfort—Lovastatin—atherosclerosis	0.000676	0.00258	CcSEcCtD
Vardenafil—Vertigo—Simvastatin—atherosclerosis	0.000676	0.00258	CcSEcCtD
Vardenafil—Myalgia—Ezetimibe—atherosclerosis	0.000672	0.00256	CcSEcCtD
Vardenafil—Chest pain—Ezetimibe—atherosclerosis	0.000672	0.00256	CcSEcCtD
Vardenafil—Arthralgia—Ezetimibe—atherosclerosis	0.000672	0.00256	CcSEcCtD
Vardenafil—Dry mouth—Lovastatin—atherosclerosis	0.00067	0.00256	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000667	0.00255	CcSEcCtD
Vardenafil—Muscle spasms—Niacin—atherosclerosis	0.000664	0.00254	CcSEcCtD
Vardenafil—Discomfort—Ezetimibe—atherosclerosis	0.000664	0.00253	CcSEcCtD
Vardenafil—Pain—Rosuvastatin—atherosclerosis	0.000662	0.00253	CcSEcCtD
Vardenafil—Dry mouth—Ezetimibe—atherosclerosis	0.000657	0.00251	CcSEcCtD
Vardenafil—Anaphylactic shock—Lovastatin—atherosclerosis	0.000656	0.00251	CcSEcCtD
Vardenafil—Muscle spasms—Pravastatin—atherosclerosis	0.000654	0.0025	CcSEcCtD
Vardenafil—Infection—Lovastatin—atherosclerosis	0.000652	0.00249	CcSEcCtD
Vardenafil—Vision blurred—Niacin—atherosclerosis	0.000651	0.00249	CcSEcCtD
Vardenafil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000644	0.00246	CcSEcCtD
Vardenafil—Vision blurred—Pravastatin—atherosclerosis	0.000641	0.00245	CcSEcCtD
Vardenafil—Arthralgia—Simvastatin—atherosclerosis	0.00064	0.00245	CcSEcCtD
Vardenafil—Myalgia—Simvastatin—atherosclerosis	0.00064	0.00245	CcSEcCtD
Vardenafil—Chest pain—Simvastatin—atherosclerosis	0.00064	0.00245	CcSEcCtD
Vardenafil—Infection—Ezetimibe—atherosclerosis	0.00064	0.00244	CcSEcCtD
Vardenafil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000638	0.00244	CcSEcCtD
Vardenafil—Anxiety—Simvastatin—atherosclerosis	0.000638	0.00244	CcSEcCtD
Vardenafil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000633	0.00242	CcSEcCtD
Vardenafil—Discomfort—Simvastatin—atherosclerosis	0.000633	0.00242	CcSEcCtD
Vardenafil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000631	0.00241	CcSEcCtD
Vardenafil—Angioedema—Niacin—atherosclerosis	0.000631	0.00241	CcSEcCtD
Vardenafil—Ill-defined disorder—Pravastatin—atherosclerosis	0.000631	0.00241	CcSEcCtD
Vardenafil—Skin disorder—Ezetimibe—atherosclerosis	0.000625	0.00239	CcSEcCtD
Vardenafil—Angioedema—Pravastatin—atherosclerosis	0.000621	0.00237	CcSEcCtD
Vardenafil—Vertigo—Niacin—atherosclerosis	0.000621	0.00237	CcSEcCtD
Vardenafil—Syncope—Niacin—atherosclerosis	0.000619	0.00237	CcSEcCtD
Vardenafil—Anaphylactic shock—Simvastatin—atherosclerosis	0.000614	0.00234	CcSEcCtD
Vardenafil—Malaise—Pravastatin—atherosclerosis	0.000613	0.00234	CcSEcCtD
Vardenafil—Abdominal pain—Rosuvastatin—atherosclerosis	0.000612	0.00234	CcSEcCtD
Vardenafil—Vertigo—Pravastatin—atherosclerosis	0.000611	0.00233	CcSEcCtD
Vardenafil—Palpitations—Niacin—atherosclerosis	0.00061	0.00233	CcSEcCtD
Vardenafil—Infection—Simvastatin—atherosclerosis	0.00061	0.00233	CcSEcCtD
Vardenafil—Loss of consciousness—Niacin—atherosclerosis	0.000607	0.00232	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000598	0.00228	CcSEcCtD
Vardenafil—Insomnia—Lovastatin—atherosclerosis	0.000594	0.00227	CcSEcCtD
Vardenafil—Paraesthesia—Lovastatin—atherosclerosis	0.000589	0.00225	CcSEcCtD
Vardenafil—Arthralgia—Niacin—atherosclerosis	0.000588	0.00225	CcSEcCtD
Vardenafil—Myalgia—Niacin—atherosclerosis	0.000588	0.00225	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000587	0.00224	CcSEcCtD
Vardenafil—Dyspnoea—Lovastatin—atherosclerosis	0.000585	0.00223	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000584	0.00223	CcSEcCtD
Vardenafil—Insomnia—Ezetimibe—atherosclerosis	0.000582	0.00222	CcSEcCtD
Vardenafil—Chest pain—Pravastatin—atherosclerosis	0.000579	0.00221	CcSEcCtD
Vardenafil—Arthralgia—Pravastatin—atherosclerosis	0.000579	0.00221	CcSEcCtD
Vardenafil—Myalgia—Pravastatin—atherosclerosis	0.000579	0.00221	CcSEcCtD
Vardenafil—Paraesthesia—Ezetimibe—atherosclerosis	0.000578	0.00221	CcSEcCtD
Vardenafil—Dyspepsia—Lovastatin—atherosclerosis	0.000578	0.00221	CcSEcCtD
Vardenafil—Anxiety—Pravastatin—atherosclerosis	0.000577	0.0022	CcSEcCtD
Vardenafil—Dry mouth—Niacin—atherosclerosis	0.000575	0.0022	CcSEcCtD
Vardenafil—Dyspnoea—Ezetimibe—atherosclerosis	0.000574	0.00219	CcSEcCtD
Vardenafil—Discomfort—Pravastatin—atherosclerosis	0.000572	0.00218	CcSEcCtD
Vardenafil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000571	0.00218	CcSEcCtD
Vardenafil—Dyspepsia—Ezetimibe—atherosclerosis	0.000567	0.00216	CcSEcCtD
Vardenafil—Anaphylactic shock—Niacin—atherosclerosis	0.000564	0.00215	CcSEcCtD
Vardenafil—Pain—Lovastatin—atherosclerosis	0.000561	0.00214	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000559	0.00214	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000556	0.00212	CcSEcCtD
Vardenafil—Asthenia—Rosuvastatin—atherosclerosis	0.000556	0.00212	CcSEcCtD
Vardenafil—Insomnia—Simvastatin—atherosclerosis	0.000555	0.00212	CcSEcCtD
Vardenafil—Anaphylactic shock—Pravastatin—atherosclerosis	0.000555	0.00212	CcSEcCtD
Vardenafil—Shock—Niacin—atherosclerosis	0.000555	0.00212	CcSEcCtD
Vardenafil—Infection—Pravastatin—atherosclerosis	0.000551	0.00211	CcSEcCtD
Vardenafil—Paraesthesia—Simvastatin—atherosclerosis	0.000551	0.00211	CcSEcCtD
Vardenafil—Pain—Ezetimibe—atherosclerosis	0.000551	0.0021	CcSEcCtD
Vardenafil—Tachycardia—Niacin—atherosclerosis	0.00055	0.0021	CcSEcCtD
Vardenafil—Pruritus—Rosuvastatin—atherosclerosis	0.000548	0.00209	CcSEcCtD
Vardenafil—Skin disorder—Niacin—atherosclerosis	0.000548	0.00209	CcSEcCtD
Vardenafil—Dyspnoea—Simvastatin—atherosclerosis	0.000547	0.00209	CcSEcCtD
Vardenafil—Hyperhidrosis—Niacin—atherosclerosis	0.000545	0.00208	CcSEcCtD
Vardenafil—Feeling abnormal—Lovastatin—atherosclerosis	0.000541	0.00207	CcSEcCtD
Vardenafil—Dyspepsia—Simvastatin—atherosclerosis	0.00054	0.00206	CcSEcCtD
Vardenafil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000537	0.00205	CcSEcCtD
Vardenafil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000537	0.00205	CcSEcCtD
Vardenafil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000531	0.00203	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00053	0.00202	CcSEcCtD
Vardenafil—Diarrhoea—Rosuvastatin—atherosclerosis	0.00053	0.00202	CcSEcCtD
Vardenafil—Hypotension—Niacin—atherosclerosis	0.000527	0.00201	CcSEcCtD
Vardenafil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000526	0.00201	CcSEcCtD
Vardenafil—Pain—Simvastatin—atherosclerosis	0.000525	0.002	CcSEcCtD
Vardenafil—Abdominal pain—Lovastatin—atherosclerosis	0.000519	0.00198	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000514	0.00196	CcSEcCtD
Vardenafil—Dizziness—Rosuvastatin—atherosclerosis	0.000512	0.00196	CcSEcCtD
Vardenafil—Insomnia—Niacin—atherosclerosis	0.00051	0.00195	CcSEcCtD
Vardenafil—CYP3A5—liver—atherosclerosis	0.00051	0.0108	CbGeAlD
Vardenafil—Abdominal pain—Ezetimibe—atherosclerosis	0.000509	0.00194	CcSEcCtD
Vardenafil—Paraesthesia—Niacin—atherosclerosis	0.000506	0.00193	CcSEcCtD
Vardenafil—Feeling abnormal—Simvastatin—atherosclerosis	0.000506	0.00193	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000506	0.00193	CcSEcCtD
Vardenafil—Dyspnoea—Niacin—atherosclerosis	0.000503	0.00192	CcSEcCtD
Vardenafil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000502	0.00192	CcSEcCtD
Vardenafil—Insomnia—Pravastatin—atherosclerosis	0.000502	0.00192	CcSEcCtD
Vardenafil—Somnolence—Niacin—atherosclerosis	0.000501	0.00191	CcSEcCtD
Vardenafil—Paraesthesia—Pravastatin—atherosclerosis	0.000498	0.0019	CcSEcCtD
Vardenafil—Dyspepsia—Niacin—atherosclerosis	0.000496	0.00189	CcSEcCtD
Vardenafil—Dyspnoea—Pravastatin—atherosclerosis	0.000495	0.00189	CcSEcCtD
Vardenafil—Dyspepsia—Pravastatin—atherosclerosis	0.000489	0.00187	CcSEcCtD
Vardenafil—Rash—Rosuvastatin—atherosclerosis	0.000488	0.00186	CcSEcCtD
Vardenafil—Dermatitis—Rosuvastatin—atherosclerosis	0.000488	0.00186	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000487	0.00186	CcSEcCtD
Vardenafil—Abdominal pain—Simvastatin—atherosclerosis	0.000485	0.00185	CcSEcCtD
Vardenafil—Headache—Rosuvastatin—atherosclerosis	0.000485	0.00185	CcSEcCtD
Vardenafil—Hypersensitivity—Lovastatin—atherosclerosis	0.000484	0.00185	CcSEcCtD
Vardenafil—Pain—Niacin—atherosclerosis	0.000482	0.00184	CcSEcCtD
Vardenafil—Pain—Pravastatin—atherosclerosis	0.000475	0.00181	CcSEcCtD
Vardenafil—Hypersensitivity—Ezetimibe—atherosclerosis	0.000474	0.00181	CcSEcCtD
Vardenafil—Asthenia—Lovastatin—atherosclerosis	0.000471	0.0018	CcSEcCtD
Vardenafil—Pruritus—Lovastatin—atherosclerosis	0.000464	0.00177	CcSEcCtD
Vardenafil—Asthenia—Ezetimibe—atherosclerosis	0.000462	0.00176	CcSEcCtD
Vardenafil—Gastrointestinal pain—Niacin—atherosclerosis	0.000461	0.00176	CcSEcCtD
Vardenafil—Nausea—Rosuvastatin—atherosclerosis	0.00046	0.00176	CcSEcCtD
Vardenafil—Feeling abnormal—Pravastatin—atherosclerosis	0.000457	0.00175	CcSEcCtD
Vardenafil—Pruritus—Ezetimibe—atherosclerosis	0.000455	0.00174	CcSEcCtD
Vardenafil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000454	0.00173	CcSEcCtD
Vardenafil—Hypersensitivity—Simvastatin—atherosclerosis	0.000452	0.00173	CcSEcCtD
Vardenafil—Diarrhoea—Lovastatin—atherosclerosis	0.000449	0.00171	CcSEcCtD
Vardenafil—Abdominal pain—Niacin—atherosclerosis	0.000446	0.0017	CcSEcCtD
Vardenafil—Asthenia—Simvastatin—atherosclerosis	0.00044	0.00168	CcSEcCtD
Vardenafil—Diarrhoea—Ezetimibe—atherosclerosis	0.00044	0.00168	CcSEcCtD
Vardenafil—Abdominal pain—Pravastatin—atherosclerosis	0.000439	0.00168	CcSEcCtD
Vardenafil—Pruritus—Simvastatin—atherosclerosis	0.000434	0.00166	CcSEcCtD
Vardenafil—Dizziness—Lovastatin—atherosclerosis	0.000434	0.00166	CcSEcCtD
Vardenafil—Dizziness—Ezetimibe—atherosclerosis	0.000426	0.00163	CcSEcCtD
Vardenafil—Diarrhoea—Simvastatin—atherosclerosis	0.00042	0.0016	CcSEcCtD
Vardenafil—Vomiting—Lovastatin—atherosclerosis	0.000417	0.00159	CcSEcCtD
Vardenafil—Hypersensitivity—Niacin—atherosclerosis	0.000415	0.00159	CcSEcCtD
Vardenafil—Rash—Lovastatin—atherosclerosis	0.000414	0.00158	CcSEcCtD
Vardenafil—Dermatitis—Lovastatin—atherosclerosis	0.000413	0.00158	CcSEcCtD
Vardenafil—Headache—Lovastatin—atherosclerosis	0.000411	0.00157	CcSEcCtD
Vardenafil—Vomiting—Ezetimibe—atherosclerosis	0.000409	0.00156	CcSEcCtD
Vardenafil—Hypersensitivity—Pravastatin—atherosclerosis	0.000409	0.00156	CcSEcCtD
Vardenafil—Dizziness—Simvastatin—atherosclerosis	0.000406	0.00155	CcSEcCtD
Vardenafil—Rash—Ezetimibe—atherosclerosis	0.000406	0.00155	CcSEcCtD
Vardenafil—Dermatitis—Ezetimibe—atherosclerosis	0.000406	0.00155	CcSEcCtD
Vardenafil—Asthenia—Niacin—atherosclerosis	0.000404	0.00154	CcSEcCtD
Vardenafil—Headache—Ezetimibe—atherosclerosis	0.000403	0.00154	CcSEcCtD
Vardenafil—Pruritus—Niacin—atherosclerosis	0.000399	0.00152	CcSEcCtD
Vardenafil—Asthenia—Pravastatin—atherosclerosis	0.000398	0.00152	CcSEcCtD
Vardenafil—Pruritus—Pravastatin—atherosclerosis	0.000393	0.0015	CcSEcCtD
Vardenafil—Vomiting—Simvastatin—atherosclerosis	0.00039	0.00149	CcSEcCtD
Vardenafil—Nausea—Lovastatin—atherosclerosis	0.00039	0.00149	CcSEcCtD
Vardenafil—Rash—Simvastatin—atherosclerosis	0.000387	0.00148	CcSEcCtD
Vardenafil—Dermatitis—Simvastatin—atherosclerosis	0.000387	0.00148	CcSEcCtD
Vardenafil—Diarrhoea—Niacin—atherosclerosis	0.000386	0.00147	CcSEcCtD
Vardenafil—Headache—Simvastatin—atherosclerosis	0.000385	0.00147	CcSEcCtD
Vardenafil—CYP3A4—liver—atherosclerosis	0.000382	0.0081	CbGeAlD
Vardenafil—Nausea—Ezetimibe—atherosclerosis	0.000382	0.00146	CcSEcCtD
Vardenafil—Diarrhoea—Pravastatin—atherosclerosis	0.00038	0.00145	CcSEcCtD
Vardenafil—Dizziness—Niacin—atherosclerosis	0.000373	0.00142	CcSEcCtD
Vardenafil—Dizziness—Pravastatin—atherosclerosis	0.000367	0.0014	CcSEcCtD
Vardenafil—Nausea—Simvastatin—atherosclerosis	0.000365	0.00139	CcSEcCtD
Vardenafil—Vomiting—Niacin—atherosclerosis	0.000358	0.00137	CcSEcCtD
Vardenafil—Rash—Niacin—atherosclerosis	0.000355	0.00136	CcSEcCtD
Vardenafil—Dermatitis—Niacin—atherosclerosis	0.000355	0.00136	CcSEcCtD
Vardenafil—Headache—Niacin—atherosclerosis	0.000353	0.00135	CcSEcCtD
Vardenafil—Vomiting—Pravastatin—atherosclerosis	0.000353	0.00135	CcSEcCtD
Vardenafil—Rash—Pravastatin—atherosclerosis	0.00035	0.00134	CcSEcCtD
Vardenafil—Dermatitis—Pravastatin—atherosclerosis	0.00035	0.00134	CcSEcCtD
Vardenafil—Headache—Pravastatin—atherosclerosis	0.000348	0.00133	CcSEcCtD
Vardenafil—Nausea—Niacin—atherosclerosis	0.000335	0.00128	CcSEcCtD
Vardenafil—Nausea—Pravastatin—atherosclerosis	0.00033	0.00126	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—CCL2—atherosclerosis	5.33e-05	0.000369	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—F2—atherosclerosis	5.33e-05	0.000369	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF1—atherosclerosis	5.24e-05	0.000363	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CG—atherosclerosis	5.23e-05	0.000363	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AGER—atherosclerosis	5.19e-05	0.00036	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NCF1—atherosclerosis	5.17e-05	0.000359	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PRKCG—atherosclerosis	5.14e-05	0.000356	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOB—atherosclerosis	5.11e-05	0.000354	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CG—atherosclerosis	5.1e-05	0.000353	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—F2—atherosclerosis	5.03e-05	0.000349	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD36—atherosclerosis	5.02e-05	0.000348	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—atherosclerosis	4.98e-05	0.000345	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SERPINE1—atherosclerosis	4.97e-05	0.000345	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—INS—atherosclerosis	4.95e-05	0.000343	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AGT—atherosclerosis	4.95e-05	0.000343	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR2—atherosclerosis	4.88e-05	0.000339	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDNRA—atherosclerosis	4.88e-05	0.000339	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—MAPK3—atherosclerosis	4.88e-05	0.000339	CbGpPWpGaD
Vardenafil—PDE1B—Disease—LPL—atherosclerosis	4.88e-05	0.000338	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL2—atherosclerosis	4.87e-05	0.000338	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CYBA—atherosclerosis	4.86e-05	0.000337	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—INS—atherosclerosis	4.83e-05	0.000335	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CG—atherosclerosis	4.82e-05	0.000334	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF1—atherosclerosis	4.79e-05	0.000332	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PLAT—atherosclerosis	4.76e-05	0.00033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GHRL—atherosclerosis	4.76e-05	0.00033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PARP1—atherosclerosis	4.76e-05	0.00033	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOS3—atherosclerosis	4.75e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL2—atherosclerosis	4.75e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PRKCG—atherosclerosis	4.74e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF1—atherosclerosis	4.67e-05	0.000324	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PDGFB—atherosclerosis	4.63e-05	0.000321	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—atherosclerosis	4.59e-05	0.000318	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—F2—atherosclerosis	4.57e-05	0.000317	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—atherosclerosis	4.56e-05	0.000316	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SERPINE1—atherosclerosis	4.55e-05	0.000315	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CRP—atherosclerosis	4.52e-05	0.000314	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—NFKB1—atherosclerosis	4.52e-05	0.000313	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.5e-05	0.000312	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK8—atherosclerosis	4.44e-05	0.000308	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.44e-05	0.000308	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SERPINE1—atherosclerosis	4.43e-05	0.000307	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCG1—atherosclerosis	4.43e-05	0.000307	CbGpPWpGaD
Vardenafil—PDE6G—Disease—STAT3—atherosclerosis	4.42e-05	0.000307	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—atherosclerosis	4.39e-05	0.000304	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CG—atherosclerosis	4.37e-05	0.000303	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOS3—atherosclerosis	4.34e-05	0.000301	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TLR4—atherosclerosis	4.34e-05	0.000301	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MAPK3—atherosclerosis	4.31e-05	0.000299	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PDGFB—atherosclerosis	4.27e-05	0.000296	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOS3—atherosclerosis	4.23e-05	0.000293	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAPK3—atherosclerosis	4.23e-05	0.000293	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCL8—atherosclerosis	4.21e-05	0.000292	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—atherosclerosis	4.18e-05	0.00029	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KNG1—atherosclerosis	4.18e-05	0.00029	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LCAT—atherosclerosis	4.16e-05	0.000289	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—FABP4—atherosclerosis	4.16e-05	0.000289	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ICAM1—atherosclerosis	4.16e-05	0.000288	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGTR1—atherosclerosis	4.15e-05	0.000288	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—atherosclerosis	4.1e-05	0.000284	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOE—atherosclerosis	4.09e-05	0.000283	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA4—atherosclerosis	4.09e-05	0.000283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL2—atherosclerosis	4.07e-05	0.000282	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—atherosclerosis	4.07e-05	0.000282	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CAV1—atherosclerosis	4.05e-05	0.000281	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PLG—atherosclerosis	4.05e-05	0.000281	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOA1—atherosclerosis	4.04e-05	0.00028	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP7A1—atherosclerosis	4.01e-05	0.000278	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—atherosclerosis	4e-05	0.000278	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK3—atherosclerosis	3.88e-05	0.000269	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCL8—atherosclerosis	3.85e-05	0.000267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SOCS3—atherosclerosis	3.83e-05	0.000266	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS2—atherosclerosis	3.81e-05	0.000264	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—atherosclerosis	3.81e-05	0.000264	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NFKB1—atherosclerosis	3.77e-05	0.000261	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCL8—atherosclerosis	3.75e-05	0.00026	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP27A1—atherosclerosis	3.71e-05	0.000257	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK8—atherosclerosis	3.7e-05	0.000257	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP3—atherosclerosis	3.7e-05	0.000257	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—atherosclerosis	3.69e-05	0.000256	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF2—atherosclerosis	3.68e-05	0.000255	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—atherosclerosis	3.63e-05	0.000251	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOB—atherosclerosis	3.58e-05	0.000248	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—atherosclerosis	3.57e-05	0.000247	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCL8—atherosclerosis	3.55e-05	0.000246	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDN1—atherosclerosis	3.52e-05	0.000244	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	3.52e-05	0.000244	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA2—atherosclerosis	3.52e-05	0.000244	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	3.52e-05	0.000244	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALOX15—atherosclerosis	3.52e-05	0.000244	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL5—atherosclerosis	3.49e-05	0.000242	CbGpPWpGaD
Vardenafil—PDE1B—Disease—INS—atherosclerosis	3.49e-05	0.000242	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—atherosclerosis	3.48e-05	0.000242	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCG5—atherosclerosis	3.47e-05	0.000241	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NFKB1—atherosclerosis	3.45e-05	0.000239	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—atherosclerosis	3.42e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LPL—atherosclerosis	3.42e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—atherosclerosis	3.4e-05	0.000235	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK8—atherosclerosis	3.39e-05	0.000235	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT3—atherosclerosis	3.39e-05	0.000235	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NFKB1—atherosclerosis	3.36e-05	0.000233	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPA—atherosclerosis	3.35e-05	0.000233	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCG—atherosclerosis	3.32e-05	0.00023	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK8—atherosclerosis	3.3e-05	0.000229	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—atherosclerosis	3.29e-05	0.000228	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BGN—atherosclerosis	3.25e-05	0.000225	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK3—atherosclerosis	3.24e-05	0.000224	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—atherosclerosis	3.23e-05	0.000224	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL8—atherosclerosis	3.22e-05	0.000223	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA5—atherosclerosis	3.22e-05	0.000223	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—atherosclerosis	3.21e-05	0.000222	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.19e-05	0.000221	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFNG—atherosclerosis	3.16e-05	0.000219	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—atherosclerosis	3.14e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—atherosclerosis	3.13e-05	0.000217	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—atherosclerosis	3.1e-05	0.000215	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	3.1e-05	0.000215	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—atherosclerosis	3.09e-05	0.000214	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—atherosclerosis	3.06e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—atherosclerosis	3.05e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—atherosclerosis	3.02e-05	0.000209	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLTP—atherosclerosis	3e-05	0.000208	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDGFB—atherosclerosis	2.99e-05	0.000208	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALOX5—atherosclerosis	2.99e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK3—atherosclerosis	2.96e-05	0.000205	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGT—atherosclerosis	2.92e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—atherosclerosis	2.91e-05	0.000202	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK3—atherosclerosis	2.88e-05	0.0002	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—atherosclerosis	2.87e-05	0.000199	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—atherosclerosis	2.86e-05	0.000198	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—atherosclerosis	2.86e-05	0.000198	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—atherosclerosis	2.85e-05	0.000198	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—atherosclerosis	2.84e-05	0.000197	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CAV1—atherosclerosis	2.84e-05	0.000197	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOA1—atherosclerosis	2.83e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—atherosclerosis	2.82e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—atherosclerosis	2.8e-05	0.000194	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—atherosclerosis	2.8e-05	0.000194	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—atherosclerosis	2.73e-05	0.00019	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—F2—atherosclerosis	2.7e-05	0.000187	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NAMPT—atherosclerosis	2.68e-05	0.000186	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LIPC—atherosclerosis	2.67e-05	0.000185	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOC3—atherosclerosis	2.65e-05	0.000184	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NFKB1—atherosclerosis	2.63e-05	0.000183	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LDLR—atherosclerosis	2.63e-05	0.000183	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—atherosclerosis	2.62e-05	0.000182	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.6e-05	0.000181	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.6e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK8—atherosclerosis	2.59e-05	0.000179	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CG—atherosclerosis	2.58e-05	0.000179	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CETP—atherosclerosis	2.57e-05	0.000178	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK3—atherosclerosis	2.47e-05	0.000172	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SCARB1—atherosclerosis	2.46e-05	0.000171	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—INS—atherosclerosis	2.45e-05	0.00017	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—atherosclerosis	2.41e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—atherosclerosis	2.37e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—atherosclerosis	2.37e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—atherosclerosis	2.37e-05	0.000164	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMGCR—atherosclerosis	2.33e-05	0.000161	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK3—atherosclerosis	2.26e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—atherosclerosis	2.25e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—atherosclerosis	2.18e-05	0.000151	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—atherosclerosis	2.18e-05	0.000151	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—atherosclerosis	2.16e-05	0.00015	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—atherosclerosis	2.14e-05	0.000149	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—atherosclerosis	2.11e-05	0.000146	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK3—atherosclerosis	2.09e-05	0.000145	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCA1—atherosclerosis	2.07e-05	0.000144	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.06e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—atherosclerosis	2.03e-05	0.00014	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—atherosclerosis	2e-05	0.000138	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—atherosclerosis	1.95e-05	0.000135	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LCAT—atherosclerosis	1.93e-05	0.000134	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FABP4—atherosclerosis	1.93e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL8—atherosclerosis	1.9e-05	0.000132	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA4—atherosclerosis	1.9e-05	0.000132	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.87e-05	0.000129	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—atherosclerosis	1.84e-05	0.000127	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—atherosclerosis	1.81e-05	0.000125	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.78e-05	0.000123	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.72e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—atherosclerosis	1.72e-05	0.000119	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOB—atherosclerosis	1.7e-05	0.000118	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NFKB1—atherosclerosis	1.7e-05	0.000118	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK8—atherosclerosis	1.67e-05	0.000116	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—atherosclerosis	1.67e-05	0.000116	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.66e-05	0.000115	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—atherosclerosis	1.65e-05	0.000115	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.63e-05	0.000113	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA2—atherosclerosis	1.63e-05	0.000113	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.63e-05	0.000113	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.63e-05	0.000113	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPL—atherosclerosis	1.63e-05	0.000113	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.61e-05	0.000112	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—atherosclerosis	1.59e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPA—atherosclerosis	1.56e-05	0.000108	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CD36—atherosclerosis	1.55e-05	0.000107	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—atherosclerosis	1.55e-05	0.000107	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—atherosclerosis	1.53e-05	0.000106	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—atherosclerosis	1.53e-05	0.000106	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—atherosclerosis	1.52e-05	0.000106	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BGN—atherosclerosis	1.51e-05	0.000105	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA5—atherosclerosis	1.5e-05	0.000104	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.46e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK3—atherosclerosis	1.46e-05	0.000101	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.44e-05	9.98e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARA—atherosclerosis	1.44e-05	9.96e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—atherosclerosis	1.42e-05	9.83e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—atherosclerosis	1.41e-05	9.76e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGT—atherosclerosis	1.39e-05	9.65e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.39e-05	9.64e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—atherosclerosis	1.36e-05	9.45e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAV1—atherosclerosis	1.35e-05	9.37e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA1—atherosclerosis	1.35e-05	9.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.25e-05	8.65e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LIPC—atherosclerosis	1.24e-05	8.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOC3—atherosclerosis	1.23e-05	8.54e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.23e-05	8.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LDLR—atherosclerosis	1.22e-05	8.49e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CETP—atherosclerosis	1.2e-05	8.29e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—atherosclerosis	1.19e-05	8.23e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—INS—atherosclerosis	1.16e-05	8.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.14e-05	7.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.08e-05	7.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—atherosclerosis	1.07e-05	7.41e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—atherosclerosis	1.07e-05	7.4e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—atherosclerosis	1.02e-05	7.08e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—atherosclerosis	9.86e-06	6.84e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.64e-06	6.68e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—atherosclerosis	9.34e-06	6.48e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—atherosclerosis	8.27e-06	5.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOB—atherosclerosis	7.92e-06	5.49e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.7e-06	5.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPL—atherosclerosis	7.56e-06	5.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—atherosclerosis	7.38e-06	5.12e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CD36—atherosclerosis	7.18e-06	4.98e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.81e-06	4.72e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARA—atherosclerosis	6.68e-06	4.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGT—atherosclerosis	6.47e-06	4.49e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—atherosclerosis	6.34e-06	4.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAV1—atherosclerosis	6.28e-06	4.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA1—atherosclerosis	6.27e-06	4.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.72e-06	3.97e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—atherosclerosis	5.52e-06	3.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—INS—atherosclerosis	5.41e-06	3.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—atherosclerosis	4.96e-06	3.44e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—atherosclerosis	4.75e-06	3.29e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—atherosclerosis	4.69e-06	3.26e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.34e-06	3.01e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—atherosclerosis	2.18e-06	1.51e-05	CbGpPWpGaD
